{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T14:15:57Z","timestamp":1789913757392,"version":"4.0.1"},"reference-count":66,"publisher":"Elsevier BV","issue":"5-6","license":[{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["bmn.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Discovery Today"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1016\/j.drudis.2012.10.005","type":"journal-article","created":{"date-parts":[[2012,10,22]],"date-time":"2012-10-22T18:20:19Z","timestamp":1350930019000},"page":"290-297","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":234,"title":["Recent advances in topical ophthalmic drug delivery with lipid-based nanocarriers"],"prefix":"10.1016","volume":"18","author":[{"given":"Li","family":"Gan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanah","family":"Bartlett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Defang","family":"Ouyang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Eperjesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianping","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Gan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drudis.2012.10.005_bib0005","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1016\/j.addr.2005.09.004","article-title":"Topical and systemic drug delivery to the posterior segments","volume":"57","author":"Hughes","year":"2005","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.drudis.2012.10.005_bib0010","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.ejpb.2004.12.007","article-title":"Roles of the conjunctiva in ocular drug delivery: a review of conjunctival transport mechanisms and their regulation","volume":"60","author":"Hosoya","year":"2005","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.drudis.2012.10.005_bib0015","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.jconrel.2010.04.013","article-title":"Topical and intravitreous administration of cationic nanoemulsions to deliver antisense oligonucleotides directed towards VEGF KDR receptors to the eye","volume":"145","author":"Hagigit","year":"2010","journal-title":"J. Control. Release"},{"key":"10.1016\/j.drudis.2012.10.005_bib0020","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jconrel.2009.04.021","article-title":"Mucoadhesive effect of thiolated PEG stearate and its modified NLC for ocular drug delivery","volume":"137","author":"Shen","year":"2009","journal-title":"J. Control. Release"},{"key":"10.1016\/j.drudis.2012.10.005_bib0025","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.ejpb.2011.01.019","article-title":"Edaravone-loaded liposomes for retinal protection against oxidative stress-induced retinal damage","volume":"79","author":"Hironaka","year":"2011","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.drudis.2012.10.005_bib0030","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ijpharm.2008.08.004","article-title":"Novel microemulsion in situ electrolyte-triggered gelling system for ophthalmic delivery of lipophilic cyclosporine A: in vitro and in vivo results","volume":"365","author":"Gan","year":"2009","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.drudis.2012.10.005_bib0035","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ijpharm.2009.01.001","article-title":"Topical use of Coenzyme Q(10)-loaded liposomes coated with trimethyl chitosan: tolerance, precorneal retention and anti-cataract effect","volume":"372","author":"Zhang","year":"2009","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.drudis.2012.10.005_bib0040","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.ijpharm.2008.07.017","article-title":"A controlled-release ocular delivery system for ibuprofen based on nanostructured lipid carriers","volume":"363","author":"Li","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.drudis.2012.10.005_bib0045","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.ijpharm.2008.05.028","article-title":"Ophthalmic delivery of cyclosporine A from Brij-97 microemulsion and surfactant-laden p-HEMA hydrogels","volume":"361","author":"Kapoor","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.drudis.2012.10.005_bib0050","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.1002\/jps.21201","article-title":"Liposomal phospholipid preparations of chloramphenicol for ophthalmic applications","volume":"97","author":"Mahmoud","year":"2008","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.drudis.2012.10.005_bib0055","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1615\/CritRevTherDrugCarrierSyst.v25.i6.20","article-title":"A review of the application of lipid-based systems in systemic, dermal\/transdermal, and ocular drug delivery","volume":"25","author":"Gershkovich","year":"2008","journal-title":"Crit. Rev. Ther. Drug"},{"key":"10.1016\/j.drudis.2012.10.005_bib0060","doi-asserted-by":"crossref","first-page":"467","DOI":"10.3109\/10717544.2010.483257","article-title":"Solid lipid nanoparticles for ocular drug delivery","volume":"17","author":"Seyfoddin","year":"2010","journal-title":"Drug Deliv."},{"key":"10.1016\/j.drudis.2012.10.005_bib0065","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1358\/dot.2011.47.6.1549023","article-title":"Nanotechnology in ocular delivery: current and future directions","volume":"47","author":"Sultana","year":"2011","journal-title":"Drugs Today"},{"key":"10.1016\/j.drudis.2012.10.005_bib0070","doi-asserted-by":"crossref","first-page":"537","DOI":"10.3109\/02713681003760168","article-title":"Feasibility of lipid nanoparticles for ocular delivery of anti-inflammatory drugs","volume":"35","author":"Souto","year":"2010","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.drudis.2012.10.005_bib0075","first-page":"264","article-title":"Determination of tear volume and tear flow","volume":"5","author":"Mishima","year":"1966","journal-title":"Invest. Ophthalmol."},{"key":"10.1016\/j.drudis.2012.10.005_bib0080","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1016\/j.addr.2005.07.005","article-title":"The use of mucoadhesive polymers in ocular drug delivery","volume":"57","author":"Ludwig","year":"2005","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.drudis.2012.10.005_bib0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0074-7696(03)31001-0","article-title":"Role of mucins in the function of the corneal and conjunctival epithelia","volume":"231","author":"Gipson","year":"2003","journal-title":"Int. Rev. Cytol."},{"key":"10.1016\/j.drudis.2012.10.005_bib0090","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/j.addr.2006.07.024","article-title":"Drug transport in corneal epithelium and blood-retina barrier: emerging role of transporters in ocular pharmacokinetics","volume":"58","author":"Mannermaa","year":"2006","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.drudis.2012.10.005_bib0095","first-page":"684","article-title":"Paracellular permeability of corneal and conjunctival epithelia","volume":"30","author":"Huang","year":"1989","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.drudis.2012.10.005_bib0100","unstructured":"Hom, M.M. et al. (2003) Understanding emulsion eye drop technology. Available at: http:\/\/www.revoptom.com\/content\/d\/news_review\/c\/18026\/dnnprintmode\/true\/?skinsrc=%5Bl%5Dskins\/ro2009\/pageprint&containersrc=%5Bl%5Dcontainers\/ro2009\/simple"},{"key":"10.1016\/j.drudis.2012.10.005_bib0105","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.addr.2009.11.026","article-title":"Chitosan-based nanostructures: a delivery platform for ocular therapeutics","volume":"62","author":"de la Fuente","year":"2010","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.drudis.2012.10.005_bib0110","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jconrel.2005.11.020","article-title":"W\/O microemulsions for ocular delivery: evaluation of ocular irritation and precorneal retention","volume":"111","author":"Alany","year":"2006","journal-title":"J. Control. Release"},{"key":"10.1016\/j.drudis.2012.10.005_bib0115","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1136\/bjo.2004.051391","article-title":"Systemic FK506 improved tear secretion in dry eye associated with chronic graft versus host disease","volume":"89","author":"Aoki","year":"2005","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.drudis.2012.10.005_bib0120","unstructured":"Furness, G. (2004) Novagali cationic emulsions \u2013 a purely positive drug delivery system. Available at: http:\/\/www.touchhealthsciences.com\/articles\/novagali-cationic-emulsions-purely-positive-drug-delivery-system"},{"key":"10.1016\/j.drudis.2012.10.005_bib0125","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1016\/j.addr.2008.09.002","article-title":"Polyoxyethylated nonionic surfactants and their applications in topical ocular drug delivery","volume":"60","author":"Jiao","year":"2008","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.drudis.2012.10.005_bib0130","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1089\/jop.2006.22.110","article-title":"Modulation of P-glycoprotein-mediated efflux by prodrug derivatization: an approach involving peptide transporter-mediated influx across rabbit cornea","volume":"22","author":"Katragadda","year":"2006","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"10.1016\/j.drudis.2012.10.005_bib0135","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ijpharm.2005.05.036","article-title":"Formulation of an ophthalmic lipid emulsion containing an anti-inflammatory steroidal drug, difluprednate","volume":"301","author":"Yamaguchi","year":"2005","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.drudis.2012.10.005_bib0140","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ijpharm.2011.03.041","article-title":"Novel NSAIDs ophthalmic formulation: flurbiprofen axetil emulsion with low irritancy and improved anti-inflammation effect","volume":"412","author":"Shen","year":"2011","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.drudis.2012.10.005_bib0145","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1248\/bpb.32.1266","article-title":"Mucoadhesive properties of chitosan-coated ophthalmic lipid emulsion containing indomethacin in tear fluid","volume":"32","author":"Yamaguchi","year":"2009","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.drudis.2012.10.005_bib0150","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1081\/PDT-100102035","article-title":"Influence of emulsion droplet surface charge on indomethacin ocular tissue distribution","volume":"5","author":"Klang","year":"2000","journal-title":"Pharm. Dev. Technol."},{"key":"10.1016\/j.drudis.2012.10.005_bib0155","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.ijpharm.2004.11.033","article-title":"Dispersion of microemulsion drops in HEMA hydrogel: a potential ophthalmic drug delivery vehicle","volume":"292","author":"Gulsen","year":"2005","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.drudis.2012.10.005_bib0160","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.3109\/03639041003801885","article-title":"Development of dorzolamide hydrochloride in situ gel nanoemulsion for ocular delivery","volume":"36","author":"Ammar","year":"2010","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.drudis.2012.10.005_bib0165","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S1773-2247(07)50006-7","article-title":"Liposome-encapsulated mitomycin C for the reduction of corneal healing rate and ocular toxicity","volume":"17","author":"Chetoni","year":"2007","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.drudis.2012.10.005_bib0170","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1111\/j.1755-3768.2009.01584.x","article-title":"Liposomes as an ocular delivery system of fluconazole: in-vitro studies","volume":"88","author":"Habib","year":"2010","journal-title":"Acta Ophthalmol."},{"key":"10.1016\/j.drudis.2012.10.005_bib0175","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1208\/pt0801001","article-title":"Liposomes as an ocular delivery system for acetazolamide: in vitro and in vivo studies","volume":"8","author":"Hathout","year":"2007","journal-title":"AAPS Pharmscitech."},{"key":"10.1016\/j.drudis.2012.10.005_bib0180","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1211\/jpp.61.09.0006","article-title":"Freeze-dried liposomes as potential carriers for ocular administration of cytochrome c against selenite cataract formation","volume":"61","author":"Zhang","year":"2009","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.drudis.2012.10.005_bib0185","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0168-3659(99)00192-3","article-title":"Acyclovir-containing liposomes for potential ocular delivery. Corneal penetration and absorption","volume":"63","author":"Law","year":"2000","journal-title":"J. Control. Release"},{"key":"10.1016\/j.drudis.2012.10.005_bib0190","doi-asserted-by":"crossref","first-page":"3672","DOI":"10.1016\/j.molimm.2007.04.009","article-title":"Mechanism of adjuvant activity of cationic liposome: phosphorylation of a MAP kinase, ERK and induction of chemokines","volume":"44","author":"Yan","year":"2007","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.drudis.2012.10.005_bib0195","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.ijpharm.2006.02.050","article-title":"Cationic liposomes as potential carriers for ocular administration of peptides with anti-herpetic activity","volume":"317","author":"Cortesi","year":"2006","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.drudis.2012.10.005_bib0200","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ijpharm.2009.01.001","article-title":"Topical use of Coenzyme Q(10)-loaded liposomes coated with trimethyl chitosan: tolerance, precorneal retention and anti-cataract effect","volume":"372","author":"Zhang","year":"2009","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.drudis.2012.10.005_bib0205","doi-asserted-by":"crossref","first-page":"44","DOI":"10.3109\/10837450903479988","article-title":"Ocular ciprofloxacin hydrochloride mucoadhesive chitosan-coated liposomes","volume":"16","author":"Abdelbary","year":"2011","journal-title":"Pharm. Dev. Technol."},{"key":"10.1016\/j.drudis.2012.10.005_bib0210","doi-asserted-by":"crossref","first-page":"108","DOI":"10.3109\/03639040903099751","article-title":"Mucoadhesive liposomes as ocular delivery system: physical, microbiological, and in vivo assessment","volume":"36","author":"Mehanna","year":"2010","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.drudis.2012.10.005_bib0215","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ijpharm.2009.06.020","article-title":"Liposome coated with low molecular weight chitosan and its potential use in ocular drug delivery","volume":"379","author":"Li","year":"2009","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.drudis.2012.10.005_bib0220","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.ijpharm.2010.10.020","article-title":"Protective effect of Coenzyme Q(10) against oxidative damage in human lens epithelial cells by novel ocular drug carriers","volume":"403","author":"Wang","year":"2011","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.drudis.2012.10.005_bib0225","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1248\/bpb.30.350","article-title":"Cubosomes: an overview","volume":"30","author":"Garg","year":"2007","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.drudis.2012.10.005_bib0230","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ijpharm.2010.06.015","article-title":"Self-assembled liquid crystalline nanoparticles as a novel ophthalmic delivery system for dexamethasone: improving preocular retention and ocular bioavailability","volume":"396","author":"Gan","year":"2010","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.drudis.2012.10.005_bib0235","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ijpharm.2005.09.023","article-title":"Preparation and evaluation of reverse-phase evaporation and multilamellar niosomes as ophthalmic carriers of acetazolamide","volume":"306","author":"Guinedi","year":"2005","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.drudis.2012.10.005_bib0240","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ijpharm.2007.01.019","article-title":"Study of the extent of ocular absorption of acetazolamide from a developed niosomal formulation, by microdialysis sampling of aqueous humor","volume":"338","author":"Aggarwal","year":"2007","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.drudis.2012.10.005_bib0245","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.ijpharm.2004.10.026","article-title":"Improved pharmacodynamics of timolol maleate from a mucoadhesive niosomal ophthalmic drug delivery system","volume":"290","author":"Aggarwal","year":"2005","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.drudis.2012.10.005_bib0250","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.ijpharm.2007.12.007","article-title":"Diclofenac sodium delivery to the eye: in vitro evaluation of novel solid lipid nanoparticle formulation using human cornea construct","volume":"355","author":"Attama","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.drudis.2012.10.005_bib0255","doi-asserted-by":"crossref","first-page":"134","DOI":"10.3109\/02652048.2010.539304","article-title":"A potential new therapeutic system for glaucoma: solid lipid nanoparticles containing methazolamide","volume":"28","author":"Li","year":"2011","journal-title":"J. Microencapsul."},{"key":"10.1016\/j.drudis.2012.10.005_bib0260","doi-asserted-by":"crossref","first-page":"996","DOI":"10.3109\/02713680903261405","article-title":"Cyclosporine A-loaded solid lipid nanoparticles: ocular tolerance and in vivo drug release in rabbit eyes","volume":"34","author":"Gokce","year":"2009","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.drudis.2012.10.005_bib0265","doi-asserted-by":"crossref","first-page":"475","DOI":"10.3109\/03639045.2010.522193","article-title":"Preparation and evaluation of solid lipid nanoparticles of baicalin for ocular drug delivery system in vitro and in vivo","volume":"37","author":"Liu","year":"2011","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.drudis.2012.10.005_bib0270","article-title":"Development of solid lipid nanoparticles and nanostructured lipid carriers for improving ocular delivery of acyclovir","author":"Seyfoddin","year":"2012","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.drudis.2012.10.005_bib0275","doi-asserted-by":"crossref","first-page":"191","DOI":"10.3109\/10611860903338462","article-title":"Preparation, characterization, and evaluation of gatifloxacin loaded solid lipid nanoparticles as colloidal ocular drug delivery system","volume":"18","author":"Kalam","year":"2010","journal-title":"J. Drug Target."},{"key":"10.1016\/j.drudis.2012.10.005_bib0280","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.ijpharm.2010.10.008","article-title":"Thiolated nanostructured lipid carriers as a potential ocular drug delivery system for cyclosporine A: improving in vivo ocular distribution","volume":"402","author":"Shen","year":"2010","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.drudis.2012.10.005_bib0285","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ijpharm.2010.10.013","article-title":"Nanostructured lipid carrier (NLC) coated with chitosan oligosaccharides and its potential use in ocular drug delivery system","volume":"403","author":"Luo","year":"2011","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.drudis.2012.10.005_bib0290","doi-asserted-by":"crossref","first-page":"045101","DOI":"10.1088\/0957-4484\/22\/4\/045101","article-title":"Optimizing flurbiprofen-loaded NLC by central composite factorial design for ocular delivery","volume":"22","author":"Gonzalez-Mira","year":"2011","journal-title":"Nanotechnology"},{"key":"10.1016\/j.drudis.2012.10.005_bib0295","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.colsurfb.2011.06.025","article-title":"Nanostructured lipid carriers for triamcinolone acetonide delivery to the posterior segment of the eye","volume":"88","author":"Araujo","year":"2011","journal-title":"Colloids Surf. B"},{"key":"10.1016\/j.drudis.2012.10.005_bib0300","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cis.2007.02.003","article-title":"An overview of lipid membrane supported by colloidal particles","volume":"133","author":"Troutier","year":"2007","journal-title":"Adv. Colloid Interface Sci."},{"key":"10.1016\/j.drudis.2012.10.005_bib0305","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1016\/j.biomaterials.2006.11.028","article-title":"Ocular drug delivery by liposome-chitosan nanoparticle complexes (LCS-NP)","volume":"28","author":"Diebold","year":"2007","journal-title":"Biomaterials"},{"key":"10.1016\/j.drudis.2012.10.005_bib0310","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/00006324-200007000-00010","article-title":"Prevalence of dry eye subtypes in clinical optometric practice","volume":"77","author":"Albietz","year":"2000","journal-title":"Optom. Vis. Sci."},{"key":"10.1016\/j.drudis.2012.10.005_bib0315","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1001\/archopht.118.9.1264","article-title":"Prevalence of and risk factors for dry eye syndrome","volume":"118","author":"Moss","year":"2000","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.drudis.2012.10.005_bib0320","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1097\/00006324-199708000-00023","article-title":"A patient questionnaire approach to estimating the prevalence of dry eye symptoms in patients presenting to optometric practices across Canada","volume":"74","author":"Doughty","year":"1997","journal-title":"Optom. Vis. Sci."},{"key":"10.1016\/j.drudis.2012.10.005_bib0325","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1097\/00006324-199912000-00019","article-title":"Symptoms of ocular irritation in patients diagnosed with dry eye","volume":"76","author":"Nichols","year":"1999","journal-title":"Optom. Vis. Sci."},{"key":"10.1016\/j.drudis.2012.10.005_bib0330","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1097\/00003226-200108000-00011","article-title":"Characterization of ocular surface symptoms from optometric practices in North America","volume":"20","author":"Begley","year":"2001","journal-title":"Cornea"}],"container-title":["Drug Discovery Today"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644612003583?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644612003583?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T12:14:49Z","timestamp":1761221689000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1359644612003583"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3]]},"references-count":66,"journal-issue":{"issue":"5-6","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["S1359644612003583"],"URL":"https:\/\/doi.org\/10.1016\/j.drudis.2012.10.005","relation":{},"ISSN":["1359-6446"],"issn-type":[{"value":"1359-6446","type":"print"}],"subject":[],"published":{"date-parts":[[2013,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recent advances in topical ophthalmic drug delivery with lipid-based nanocarriers","name":"articletitle","label":"Article Title"},{"value":"Drug Discovery Today","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drudis.2012.10.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Ltd. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}